NCT07179679 2025-12-11A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Recruiting42 enrolled